Fda - Articles - Page 9 | WholeFoods Magazine

CRN Challenges FDA Course on Drug Preclusion

June 2, 2023

The Council for Responsible Nutrition (CRN) has submitted a Citizen Petition to the U.S. Food and Drug Administration (FDA) calling for the agency to reconsider its interpretation of the Drug Preclusion Clause.

Assorted Nutritional Supplements and supplement bottles

Dietary Supplements Forum to Focus on FTC Compliance, Counterfeit Supps, Personalized Nutrition, and More

With new areas of concern garnering attention from FDA and FTC, this year’s conference will deliver critical updates on the latest policy, regulatory and business developments for the supplement industry.

May 9, 2023

WholeFoods Magazine Staff

The Council for Responsible Nutrition (CRN) and the American Conference Institute (ACI) once again are teaming up for Legal, Regulatory, and Compliance Forum on Dietary Supplements. Back for the 11th year, this year's event is taking place June 28 – 29, 2023 (in person in NYC, as well as livestreamed).

Hemp plant and pipette with a CBD oil on wet metal surface

NPA: FDA CBD Study "Disingenuous at Best, Harmful at Worst"

The trade group explained that FDA used drug standards to conduct a supplement study.

April 27, 2023

Maggie Jaqua, Content Director

The Office of Food Additive Safety, Center for Food Safety and Applied Nutrition (CFSAN) has published its review the oral toxicity of cannabidiol (CBD). NPA weighs in.

newspaper cartoon with coffee and glasses and microphone.jpg

Natural Products Industry News Briefs: NutriLeads, Nutriventia, and More

There's a lot happening in the natural products industry. Find out about the latest!

April 26, 2023

WholeFoods Magazine Staff

There is a lot happening in the natural products industry. Read up on the latest!

NPA, ANH File Citizen’s Petition with FDA on NMN

“Issues surrounding NAC and NMN are glaring examples of the FDA fundamentally failing American consumers and industry," said NPA's Daniel Fabricant, Ph.D.

March 21, 2023

Maggie Jaqua, Content Director

In November 2022, a notification by the Food and Drug Administration (FDA) declared that beta-nicotinamide mononucleotide (NMN) is not a legal dietary ingredient. In response, the Natural Products Association (NPA), along with the Alliance for Natural Health (ANH), submitted a Citizen’s Petition to FDA.

FDA Releases Dietary Supplement Ingredient Directory; Industry Reacts

“This sort of communication, without providing any new information for stakeholders, will reinforce industry misgivings about giving the agency even more authority," said AHPA's Michael McGuffin.

March 15, 2023

Maggie Jaqua, Content Director

The FDA has released its new Dietary Supplement Ingredient Directory, which it says is intended to be "a one stop shop of ingredient information that was previously found on different FDA webpages."

Organic fruit, vegetables, healthy drink, and nutrition supplements.

Industry Groups Submit Comment to FDA on Proposed Rule for “Healthy” Claims

The rule would update the “healthy” implied nutrient content claim

March 2, 2023

Maggie Jaqua, Content Director

The Council for Responsible Nutrition (CRN) and the American Herbal Products Association (AHPA) were among those who submitted comments to FDA on its proposed rule to update “healthy” implied nutrient content claims.

Nicotinamide mononucleotide. White pills forming shape to NMN alphabet on wooden background.

NPA Asks Amazon to Restore NMN Sales

Products containing NMN would be banned from the site after March 13, 2023.

March 2, 2023

Maggie Jaqua, Content Director

Following the November 2022 notification by the Food and Drug Administration (FDA) that beta-nicotinamide mononucleotide (NMN) is not a legal dietary ingredient, Amazon’s Restricted Products Team emailed sellers in February that products containing NMN would be banned after March 13, 2023.

Regulatory-Compliance-GettyImages-645397720-1536x1315.jpg

Ensuring Regulatory Compliance When Bringing a Product to Market

Getting Regulatory Right is Brand Insurance

February 27, 2023

Lesley O’Connor, Senior Manager of Regulatory Affairs, Vitaquest International

The nutraceuticals market is experiencing a sustained period of growth fueled by consumers focused on improving personal health. As marketers of nutraceutical supplements bring new products to market, it is critical that they comply with all regulatory requirements to protect consumers and themselves.

FDA: Existing Regulatory Frameworks for Foods & Supplements Not Appropriate for CBD

January 26, 2023

Maggie Jaqua, Content Director

Silver Spring, MD—There needs to be new regulatory pathway for cannabidiol (CBD) that balances consumers’ desire for access to CBD products with regulatory oversight that can manage risks. That's the conclusion the U.S. Food and Drug Administration (FDA) has reached after convening an internal working group to explore potential regulatory...